+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Respiratory Infection Diagnostics Market - Global Forecast 2026-2032- Product Image
Respiratory Infection Diagnostics Market - Global Forecast 2026-2032- Product Image
New

Respiratory Infection Diagnostics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 180 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6012371
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The respiratory infection diagnostics market is undergoing significant transformation, shaped by technological innovation, evolving clinical workflows, and an increasingly complex regulatory environment. Senior leaders evaluating solutions today need to consider a landscape marked by rapid advances in diagnostic modalities, cross-sector collaboration, and shifting operational priorities.

Market Snapshot

The Respiratory Infection Diagnostics Market grew from USD 88.38 billion in 2025 to USD 94.84 billion in 2026. It is expected to continue growing at a CAGR of 7.37%, reaching USD 145.44 billion by 2032. Advances in platform performance, digital health integration, and scalable testing strategies are enabling laboratories, clinics, and public health authorities to more efficiently detect and manage respiratory pathogens amid evolving healthcare demands.

Scope & Segmentation

  • Technology Modalities: Immunoassay (including Enzyme Linked Immunosorbent Assay, Lateral Flow Immunoassay), Microbiological Culture (Automated Culture Systems, Conventional Culture), Molecular Diagnostics (Loop Mediated Isothermal Amplification, Polymerase Chain Reaction), Sequencing (Next Generation Sequencing, Sanger Sequencing).
  • Sample Types: Blood, Nasal Swab, Saliva, Sputum, Throat Swab.
  • Test Modes: Laboratory Based and Point Of Care testing environments, facilitating operational flexibility and tailored deployment strategies.
  • Infection Targets: Coronavirus Disease, Influenza, Respiratory Syncytial Virus; each with distinct surveillance and clinical implications.
  • End User Contexts: Clinics, Home Care Settings, Hospitals, Research Laboratories; these settings influence packaging, user training, and reporting requirements.
  • Regional Coverage: Comprehensive analysis includes the Americas, Europe, Middle East & Africa, and Asia-Pacific, each with unique infrastructural, regulatory, and operational characteristics.

Key Takeaways

  • Clinical innovation is accelerating, with platform convergence merging molecular and immunoassay-based diagnostics to meet evolving demands for accuracy and convenience.
  • Integration with digital health systems and electronic health records is advancing, enhancing real-time data capture, workflow automation, and public health reporting.
  • The regulatory landscape is evolving, with streamlined approval pathways supporting faster clinical adoption, while driving higher expectations for real-world evidence.
  • Manufacturing and procurement are adapting to prioritize supply continuity and scalability through distributed sourcing and localization initiatives.
  • Diagnostic resilience is a focal point, with supply chain agility and operational flexibility recognized as strategic priorities over both near-term and multi-seasonal horizons.
  • Stakeholder partnerships—spanning clinical settings, payors, and public health agencies—are essential for validation, reimbursement optimization, and scalable deployment.

Tariff Impact on Supply Chains and Procurement

Recent tariffs on diagnostic components and finished devices are prompting shifts in procurement and supply chain strategies. Increased landed costs for reagents and hardware drive buyers to diversify sourcing, expand buffer inventories, and consider longer-term contracts to mitigate risk. Manufacturers are localizing production and re-evaluating product design to reduce vulnerability related to cross-border trade. Administrative complexity in international transactions and evolving distributor agreements further impact procurement cycles and cost structures.

Methodology & Data Sources

This report leverages extensive primary engagement—including interviews with laboratory directors, procurement leads, and regulatory experts—combined with secondary intelligence such as peer-reviewed literature and product specifications. Scenario analysis, supply chain mapping, and case study validation were applied to ensure findings accurately reflect market realities and practitioner perspectives.

Why This Report Matters

  • Facilitates informed decision-making by providing actionable segmentation insights and highlighting operational nuances in respiratory diagnostics.
  • Supports strategic planning with clear perspectives on innovation pathways, tariff implications, and regional adoption dynamics within the respiratory infection diagnostics market.
  • Enables leaders to prioritize supply chain resilience, digital interoperability, and patient-centric deployment amid a rapidly changing regulatory and clinical landscape.

Conclusion

The respiratory infection diagnostics landscape is evolving as technologies integrate with clinical workflows and supply strategies adapt to external pressures. Organizations investing in interoperability, local manufacturing, and evidence-based deployment will be best positioned to sustain effective diagnostic delivery in the years ahead.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Respiratory Infection Diagnostics Market, by Technology
8.1. Immunoassay
8.1.1. Enzyme Linked Immunosorbent Assay
8.1.2. Lateral Flow Immunoassay
8.2. Microbiological Culture
8.2.1. Automated Culture Systems
8.2.2. Conventional Culture
8.3. Molecular Diagnostics
8.3.1. Loop Mediated Isothermal Amplification
8.3.2. Polymerase Chain Reaction
8.4. Sequencing
8.4.1. Next Generation Sequencing
8.4.2. Sanger Sequencing
9. Respiratory Infection Diagnostics Market, by Sample Type
9.1. Blood
9.2. Nasal Swab
9.3. Saliva
9.4. Sputum
9.5. Throat Swab
10. Respiratory Infection Diagnostics Market, by Test Mode
10.1. Laboratory Based
10.2. Point Of Care
11. Respiratory Infection Diagnostics Market, by Infection Type
11.1. Coronavirus Disease
11.2. Influenza
11.3. Respiratory Syncytial Virus
12. Respiratory Infection Diagnostics Market, by End User
12.1. Clinics
12.2. Home Care Settings
12.3. Hospitals
12.4. Research Laboratories
13. Respiratory Infection Diagnostics Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Respiratory Infection Diagnostics Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Respiratory Infection Diagnostics Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Respiratory Infection Diagnostics Market
17. China Respiratory Infection Diagnostics Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Agilent Technologies, Inc.
18.7. Autobio Diagnostics Co.
18.8. Becton, Dickinson and Company
18.9. Bio-Rad Laboratories, Inc.
18.10. bioMérieux, Inc.
18.11. Cardinal Health, Inc.
18.12. COSMED srl
18.13. Danaher Corporation
18.14. F. Hoffmann-La Roche AG.
18.15. Hologic Inc.
18.16. Illumina, Inc.
18.17. Johnson & Johnson Services, Inc.
18.18. Koninklijke Philips N.V.
18.19. Maccura Biotechnology Co. Ltd
18.20. Mindray Medical International Limited
18.21. NIHON KOHDEN CORPORATION
18.22. QIAGEN
18.23. Shanghai Kehua Bio-Engineering Co. Ltd
18.24. Thermo Fisher Scientific Holdings, Inc
18.25. Xiamen Zeesan Biotech Co., Ltd.
List of Figures
FIGURE 1. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CONVENTIONAL CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CONVENTIONAL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CONVENTIONAL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY NASAL SWAB, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY NASAL SWAB, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY NASAL SWAB, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SPUTUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SPUTUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SPUTUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY THROAT SWAB, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY THROAT SWAB, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY THROAT SWAB, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CORONAVIRUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CORONAVIRUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CORONAVIRUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFLUENZA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFLUENZA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY RESPIRATORY SYNCYTIAL VIRUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY RESPIRATORY SYNCYTIAL VIRUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY RESPIRATORY SYNCYTIAL VIRUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. EUROPE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. EUROPE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 132. EUROPE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 133. EUROPE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2032 (USD MILLION)
TABLE 134. EUROPE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 135. EUROPE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 136. EUROPE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 137. EUROPE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2032 (USD MILLION)
TABLE 138. EUROPE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 139. EUROPE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 152. AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 153. AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2032 (USD MILLION)
TABLE 154. AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 155. AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 156. AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 157. AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2032 (USD MILLION)
TABLE 158. AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 159. AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. ASEAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. ASEAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 173. ASEAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 174. ASEAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2032 (USD MILLION)
TABLE 175. ASEAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 176. ASEAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 177. ASEAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 178. ASEAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2032 (USD MILLION)
TABLE 179. ASEAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 180. ASEAN RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. GCC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. GCC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 183. GCC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 184. GCC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2032 (USD MILLION)
TABLE 185. GCC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 186. GCC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 187. GCC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 188. GCC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2032 (USD MILLION)
TABLE 189. GCC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 190. GCC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. BRICS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. BRICS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 203. BRICS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 204. BRICS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2032 (USD MILLION)
TABLE 205. BRICS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 206. BRICS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 207. BRICS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 208. BRICS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2032 (USD MILLION)
TABLE 209. BRICS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 210. BRICS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. G7 RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 212. G7 RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 213. G7 RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 214. G7 RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2032 (USD MILLION)
TABLE 215. G7 RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 216. G7 RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 217. G7 RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 218. G7 RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2032 (USD MILLION)
TABLE 219. G7 RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 220. G7 RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. NATO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. NATO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 223. NATO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 224. NATO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2032 (USD MILLION)
TABLE 225. NATO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 226. NATO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 227. NATO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 228. NATO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2032 (USD MILLION)
TABLE 229. NATO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 230. NATO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 242. CHINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 243. CHINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 244. CHINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 245. CHINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2032 (USD MILLION)
TABLE 246. CHINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 247. CHINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 248. CHINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 249. CHINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2032 (USD MILLION)
TABLE 250. CHINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2032 (USD MILLION)
TABLE 251. CHINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Respiratory Infection Diagnostics market report include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Autobio Diagnostics Co.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux, Inc.
  • Cardinal Health, Inc.
  • COSMED srl
  • Danaher Corporation
  • F. Hoffmann-La Roche AG.
  • Hologic Inc.
  • Illumina, Inc.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • Maccura Biotechnology Co. Ltd
  • Mindray Medical International Limited
  • NIHON KOHDEN CORPORATION
  • QIAGEN
  • Shanghai Kehua Bio-Engineering Co. Ltd
  • Thermo Fisher Scientific Holdings, Inc
  • Xiamen Zeesan Biotech Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages180
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 94.84 Billion
Forecasted Market Value ( USD ) by 2032 $ 145.44 Billion
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

RSV Diagnostics Market - Global Forecast 2026-2032 - Product Image

RSV Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Human Metapneumovirus Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Human Metapneumovirus Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 181 Pages
  • Global
From
Infectious Respiratory Disease Diagnostics Market - Global Forecast 2025-2030 - Product Image

Infectious Respiratory Disease Diagnostics Market - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Respiratory Infection Diagnostics Market 2025-2029 - Forecasts by Technology, Plex, Place, Product and Region, with Executive and Consultant Guides - Product Image

Respiratory Infection Diagnostics Market 2025-2029 - Forecasts by Technology, Plex, Place, Product and Region, with Executive and Consultant Guides

  • Report
  • 606 Pages
  • Global
From
RSV Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

RSV Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.